Inventor
SCHMERTZLER MICHAEL
US20 patents
⚠️ This page may combine multiple inventors who share the name “SCHMERTZLER MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHY Therapeutics LLC
13 patentsUS10940139B2Mar 9, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC3 citations83
US10870657B2Dec 22, 2020
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC4 citations83
US10588894B2Mar 17, 2020
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC4 citations83
US10221191B2Mar 5, 2019
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC5 citations83
US12168668B2Dec 17, 2024
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC1 citations72
US11026930B1Jun 8, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC2 citations72
US11000515B2May 11, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC2 citations72
US10933054B2Mar 2, 2021
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC2 citations72
US12391705B2Aug 19, 2025
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC1 citations63
US11560390B2Jan 24, 2023
Compounds for the treatment of cancer and inflammatory disease
SHY Therapeutics LLC0 citations62
US11541041B1Jan 3, 2023
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease
SHY Therapeutics LLC0 citations61
US11213515B1Jan 4, 2022
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC0 citations61
US12459951B2Nov 4, 2025
Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
SHY Therapeutics LLC0 citations45
ACCESS RADIOLOGY CORP
3 patentsUS5655084AAug 5, 1997
Radiological image interpretation apparatus and method
ACCESS RADIOLOGY CORP351 citations96
US5513101AApr 30, 1996
Radiological image interpretation apparatus and method
ACCESS RADIOLOGY CORP187 citations96
US5469353ANov 21, 1995
Radiological image interpretation apparatus and method
ACCESS RADIOLOGY CORP304 citations96
NATURON INC
3 patentsUS8034576B2Oct 11, 2011
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
NATURON INC4 citations67
US8361734B2Jan 29, 2013
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
NATURON INC1 citations56
US10370335B2Aug 6, 2019
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
NATURON INC0 citations46